Inion plans divestments as losses widen
This article was originally published in Clinica
Executive Summary
Inion, the London Stock Exchange-listed biodegradable implant maker based in Tampere, Finland, wants to divest its dental product line soon and probably also its sports medicine and craniomaxillofacial businesses eventually, CEO Auvo Kaikkonen told Clinica. "We are a bit too diversified and need to refocus on the biggest opportunities based on our current technology and pipeline products," he said.